Aposcience AG Information

Aposcience AG aspires to improve the health of patients in need of regenerative medicine by commercially exploiting the therapeutic potential of secretomes derived from white blood cells (PBMCs) isolated from peripheral blood. PBMCs are currently a waste product of all blood transfusion units.

Website	http://www.aposcience.at/
Revenue	$86.7 million
Employees	5 (1 on RocketReach)
Founded	2006
Address	Währinger Gürtel 18-20, Ebene 8 Grün, Vienna, Vienna 1090, AT
Phone	+43 664 2120557
Technologies	JavaScript , PHP , TYPO3 (view technologies)
Industry	Biotechnology Research, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Pharmaceutical
Keywords	Regenerative Medicine, Cell Therapy, Therapeutic Potential, White Blood Cells, Biotechnology, Pharmaceutical, Drug Development, Biopharma, Clinical Trials, Patient Health, Healthcare, Medical Technology, Life Sciences, Immunotherapy, Precision Medicine, Biological Therapeutics, Regenerative Treatments
Competitors	Roche, Thermo Fisher Scientific, BD, Genentech, Agilent Technologies, Illumina, bioMérieux, Bio-Rad Laboratories, QIAGEN, Sartorius +38 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies